Redwood Financial Network’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Sell
2,357
-96
-4% -$13.4K 0.22% 127
2025
Q4
$301K Hold
2,453
0.19% 137
2025
Q3
$272K Sell
2,453
-10
-0.4% -$1.14K 0.17% 141
2025
Q2
$273K Hold
2,463
0.18% 137
2025
Q1
$276K Sell
2,463
-67
-3% -$6.91K 0.21% 128
2024
Q4
$234K Buy
2,530
+98
+4% +$8.82K 0.17% 137
2024
Q3
$204K Buy
+2,432
New +$186K 0.16% 142
2024
Q1
Sell
-2,585
Closed -$209K 151
2023
Q4
$209K Buy
+2,585
New +$201K 0.2% 131
2023
Q3
Sell
-2,666
Closed -$205K 142
2023
Q2
$205K Sell
2,666
-211
-7% -$16.8K 0.19% 144
2023
Q1
$239K Buy
2,877
+4
+0.1% +$331 0.24% 129
2022
Q4
$247K Buy
+2,873
New +$228K 0.28% 114

Other funds holding GILD

Redwood Financial Network's GILD Position: Q1 2026 in Review

Redwood Financial Network reduced its Gilead Sciences (GILD) stake by 3.9% in Q1 2026, selling an estimated $13.4K and leaving 2,357 shares worth $328K. The position accounts for 0.22% of the portfolio, ranked #127.

Redwood Financial Network first reported a position in GILD in Q4 2022 and has held it in 11 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Redwood Financial Network held 2,357 shares of Gilead Sciences worth $328K as of Q1 2026.
  • Redwood Financial Network sold 96 Gilead Sciences shares in Q1 2026, an estimated $13.4K.
  • Gilead Sciences made up 0.22% of Redwood Financial Network's portfolio in Q1 2026, its #127 holding.
  • Redwood Financial Network first reported a position in Gilead Sciences in Q4 2022 and has held it in 11 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Redwood Financial Network's 13F filing for Q1 2026, filed 14 May 2026.